Spectral AI Inc (NASDAQ:MDAI), the wound care diagnostics specialist, has been included in the Russell Microcap Index following the annual Russell reconstitution, which took effect after the market close last week.
The reconstituted Russell Microcap Index will commence trading on July 1, 2024.
“Spectral AI’s addition to the Russell Microcap Index provides us with greater visibility among investors at this important time in our history,” said Peter Carlson, Spectral AI’s chief executive.
DeepView is an AI-driven predictive medical device that delivers an immediate and objective assessment of a wound’s healing potential.
Initial applications for the device involve patients with burns and diabetic foot ulcers (DFU).
“We continue to build momentum in commercializing our proprietary, AI-driven DeepView System and remain focused on creating long-term value for our shareholders,” added Carlson.
Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.